We've found
13,544
archived clinical trials in
Ovarian Cancer
We've found
13,544
archived clinical trials in
Ovarian Cancer
A Single-Arm Study Evaluating Carboplatin/Gemcitabine in Combination With BSI-201 in Patients With Platinum-Resistant Recurrent Ovarian Cancer
Updated: 2/17/2016
A Phase 2, Multi-Center, Single-Arm Study Evaluating Carboplatin/Gemcitabine in Combination With BSI-201 in Patients With Platinum-Resistant Recurrent Ovarian Cancer
Status: Enrolling
Updated: 2/17/2016
A Single-Arm Study Evaluating Carboplatin/Gemcitabine in Combination With BSI-201 in Patients With Platinum-Resistant Recurrent Ovarian Cancer
Updated: 2/17/2016
A Phase 2, Multi-Center, Single-Arm Study Evaluating Carboplatin/Gemcitabine in Combination With BSI-201 in Patients With Platinum-Resistant Recurrent Ovarian Cancer
Status: Enrolling
Updated: 2/17/2016
Click here to add this to my saved trials
Imatinib Mesylate in Combination With Docetaxel for Advanced, Platinum-Refractory Ovarian Cancer
Updated: 2/17/2016
Imatinib Mesylate (Gleevec®, STI571) in Combination With Docetaxel (Taxotere) for the Treatment of Advanced, Platinum-Refractory Ovarian Cancer and Primary Peritoneal Carcinomatosis: Hoosier Oncology Group GYN03-62
Status: Enrolling
Updated: 2/17/2016
Imatinib Mesylate in Combination With Docetaxel for Advanced, Platinum-Refractory Ovarian Cancer
Updated: 2/17/2016
Imatinib Mesylate (Gleevec®, STI571) in Combination With Docetaxel (Taxotere) for the Treatment of Advanced, Platinum-Refractory Ovarian Cancer and Primary Peritoneal Carcinomatosis: Hoosier Oncology Group GYN03-62
Status: Enrolling
Updated: 2/17/2016
Click here to add this to my saved trials
Imatinib Mesylate in Combination With Docetaxel for Advanced, Platinum-Refractory Ovarian Cancer
Updated: 2/17/2016
Imatinib Mesylate (Gleevec®, STI571) in Combination With Docetaxel (Taxotere) for the Treatment of Advanced, Platinum-Refractory Ovarian Cancer and Primary Peritoneal Carcinomatosis: Hoosier Oncology Group GYN03-62
Status: Enrolling
Updated: 2/17/2016
Imatinib Mesylate in Combination With Docetaxel for Advanced, Platinum-Refractory Ovarian Cancer
Updated: 2/17/2016
Imatinib Mesylate (Gleevec®, STI571) in Combination With Docetaxel (Taxotere) for the Treatment of Advanced, Platinum-Refractory Ovarian Cancer and Primary Peritoneal Carcinomatosis: Hoosier Oncology Group GYN03-62
Status: Enrolling
Updated: 2/17/2016
Click here to add this to my saved trials
Imatinib Mesylate in Combination With Docetaxel for Advanced, Platinum-Refractory Ovarian Cancer
Updated: 2/17/2016
Imatinib Mesylate (Gleevec®, STI571) in Combination With Docetaxel (Taxotere) for the Treatment of Advanced, Platinum-Refractory Ovarian Cancer and Primary Peritoneal Carcinomatosis: Hoosier Oncology Group GYN03-62
Status: Enrolling
Updated: 2/17/2016
Imatinib Mesylate in Combination With Docetaxel for Advanced, Platinum-Refractory Ovarian Cancer
Updated: 2/17/2016
Imatinib Mesylate (Gleevec®, STI571) in Combination With Docetaxel (Taxotere) for the Treatment of Advanced, Platinum-Refractory Ovarian Cancer and Primary Peritoneal Carcinomatosis: Hoosier Oncology Group GYN03-62
Status: Enrolling
Updated: 2/17/2016
Click here to add this to my saved trials
Imatinib Mesylate in Combination With Docetaxel for Advanced, Platinum-Refractory Ovarian Cancer
Updated: 2/17/2016
Imatinib Mesylate (Gleevec®, STI571) in Combination With Docetaxel (Taxotere) for the Treatment of Advanced, Platinum-Refractory Ovarian Cancer and Primary Peritoneal Carcinomatosis: Hoosier Oncology Group GYN03-62
Status: Enrolling
Updated: 2/17/2016
Imatinib Mesylate in Combination With Docetaxel for Advanced, Platinum-Refractory Ovarian Cancer
Updated: 2/17/2016
Imatinib Mesylate (Gleevec®, STI571) in Combination With Docetaxel (Taxotere) for the Treatment of Advanced, Platinum-Refractory Ovarian Cancer and Primary Peritoneal Carcinomatosis: Hoosier Oncology Group GYN03-62
Status: Enrolling
Updated: 2/17/2016
Click here to add this to my saved trials
Imatinib Mesylate in Combination With Docetaxel for Advanced, Platinum-Refractory Ovarian Cancer
Updated: 2/17/2016
Imatinib Mesylate (Gleevec®, STI571) in Combination With Docetaxel (Taxotere) for the Treatment of Advanced, Platinum-Refractory Ovarian Cancer and Primary Peritoneal Carcinomatosis: Hoosier Oncology Group GYN03-62
Status: Enrolling
Updated: 2/17/2016
Imatinib Mesylate in Combination With Docetaxel for Advanced, Platinum-Refractory Ovarian Cancer
Updated: 2/17/2016
Imatinib Mesylate (Gleevec®, STI571) in Combination With Docetaxel (Taxotere) for the Treatment of Advanced, Platinum-Refractory Ovarian Cancer and Primary Peritoneal Carcinomatosis: Hoosier Oncology Group GYN03-62
Status: Enrolling
Updated: 2/17/2016
Click here to add this to my saved trials
Imatinib Mesylate in Combination With Docetaxel for Advanced, Platinum-Refractory Ovarian Cancer
Updated: 2/17/2016
Imatinib Mesylate (Gleevec®, STI571) in Combination With Docetaxel (Taxotere) for the Treatment of Advanced, Platinum-Refractory Ovarian Cancer and Primary Peritoneal Carcinomatosis: Hoosier Oncology Group GYN03-62
Status: Enrolling
Updated: 2/17/2016
Imatinib Mesylate in Combination With Docetaxel for Advanced, Platinum-Refractory Ovarian Cancer
Updated: 2/17/2016
Imatinib Mesylate (Gleevec®, STI571) in Combination With Docetaxel (Taxotere) for the Treatment of Advanced, Platinum-Refractory Ovarian Cancer and Primary Peritoneal Carcinomatosis: Hoosier Oncology Group GYN03-62
Status: Enrolling
Updated: 2/17/2016
Click here to add this to my saved trials
Imatinib Mesylate in Combination With Docetaxel for Advanced, Platinum-Refractory Ovarian Cancer
Updated: 2/17/2016
Imatinib Mesylate (Gleevec®, STI571) in Combination With Docetaxel (Taxotere) for the Treatment of Advanced, Platinum-Refractory Ovarian Cancer and Primary Peritoneal Carcinomatosis: Hoosier Oncology Group GYN03-62
Status: Enrolling
Updated: 2/17/2016
Imatinib Mesylate in Combination With Docetaxel for Advanced, Platinum-Refractory Ovarian Cancer
Updated: 2/17/2016
Imatinib Mesylate (Gleevec®, STI571) in Combination With Docetaxel (Taxotere) for the Treatment of Advanced, Platinum-Refractory Ovarian Cancer and Primary Peritoneal Carcinomatosis: Hoosier Oncology Group GYN03-62
Status: Enrolling
Updated: 2/17/2016
Click here to add this to my saved trials
Imatinib Mesylate in Combination With Docetaxel for Advanced, Platinum-Refractory Ovarian Cancer
Updated: 2/17/2016
Imatinib Mesylate (Gleevec®, STI571) in Combination With Docetaxel (Taxotere) for the Treatment of Advanced, Platinum-Refractory Ovarian Cancer and Primary Peritoneal Carcinomatosis: Hoosier Oncology Group GYN03-62
Status: Enrolling
Updated: 2/17/2016
Imatinib Mesylate in Combination With Docetaxel for Advanced, Platinum-Refractory Ovarian Cancer
Updated: 2/17/2016
Imatinib Mesylate (Gleevec®, STI571) in Combination With Docetaxel (Taxotere) for the Treatment of Advanced, Platinum-Refractory Ovarian Cancer and Primary Peritoneal Carcinomatosis: Hoosier Oncology Group GYN03-62
Status: Enrolling
Updated: 2/17/2016
Click here to add this to my saved trials
Imatinib Mesylate in Combination With Docetaxel for Advanced, Platinum-Refractory Ovarian Cancer
Updated: 2/17/2016
Imatinib Mesylate (Gleevec®, STI571) in Combination With Docetaxel (Taxotere) for the Treatment of Advanced, Platinum-Refractory Ovarian Cancer and Primary Peritoneal Carcinomatosis: Hoosier Oncology Group GYN03-62
Status: Enrolling
Updated: 2/17/2016
Imatinib Mesylate in Combination With Docetaxel for Advanced, Platinum-Refractory Ovarian Cancer
Updated: 2/17/2016
Imatinib Mesylate (Gleevec®, STI571) in Combination With Docetaxel (Taxotere) for the Treatment of Advanced, Platinum-Refractory Ovarian Cancer and Primary Peritoneal Carcinomatosis: Hoosier Oncology Group GYN03-62
Status: Enrolling
Updated: 2/17/2016
Click here to add this to my saved trials
Perifosine and Docetaxel in Patients With Relapsed Epithelial Ovarian Cancer
Updated: 2/17/2016
Pharmacodynamic Trial: Molecular Marker & Imaging Studies as Primary Endpoints to Determine Optimal Biological Dosage of Perifosine, Orally Avail AKT PH Domain Inhibitor Combined w/ Docetaxel in Patients w/Relapsed Epithelial Ovarian Cancer
Status: Enrolling
Updated: 2/17/2016
Perifosine and Docetaxel in Patients With Relapsed Epithelial Ovarian Cancer
Updated: 2/17/2016
Pharmacodynamic Trial: Molecular Marker & Imaging Studies as Primary Endpoints to Determine Optimal Biological Dosage of Perifosine, Orally Avail AKT PH Domain Inhibitor Combined w/ Docetaxel in Patients w/Relapsed Epithelial Ovarian Cancer
Status: Enrolling
Updated: 2/17/2016
Click here to add this to my saved trials
A Single-Arm Study Evaluating Carboplatin/Gemcitabine in Combination With BSI-201 in Patients With Platinum-Sensitive Recurrent Ovarian Cancer
Updated: 2/17/2016
A Phase 2, Multi-Center, Single-Arm Study Evaluating Carboplatin/Gemcitabine in Combination With BSI-201 in Patients With Platinum-Sensitive Recurrent Ovarian Cancer
Status: Enrolling
Updated: 2/17/2016
A Single-Arm Study Evaluating Carboplatin/Gemcitabine in Combination With BSI-201 in Patients With Platinum-Sensitive Recurrent Ovarian Cancer
Updated: 2/17/2016
A Phase 2, Multi-Center, Single-Arm Study Evaluating Carboplatin/Gemcitabine in Combination With BSI-201 in Patients With Platinum-Sensitive Recurrent Ovarian Cancer
Status: Enrolling
Updated: 2/17/2016
Click here to add this to my saved trials
WCC# 59 Hyperthermic Intraperitoneal Chemotherapy Utilizing Carboplatin in First Recurrence Ovarian Cancer
Updated: 2/23/2016
WCC# 59: Pilot Study of Hyperthermic Intraperitoneal Chemotherapy Utilizing Carboplatin in First Recurrence
Status: Enrolling
Updated: 2/23/2016
WCC# 59 Hyperthermic Intraperitoneal Chemotherapy Utilizing Carboplatin in First Recurrence Ovarian Cancer
Updated: 2/23/2016
WCC# 59: Pilot Study of Hyperthermic Intraperitoneal Chemotherapy Utilizing Carboplatin in First Recurrence
Status: Enrolling
Updated: 2/23/2016
Click here to add this to my saved trials
Ph 1 Trial of ADI-PEG 20 Plus Cisplatin in Patients With Metastatic Melanoma
Updated: 2/24/2016
Phase 1 Trial of ADI-PEG 20 Plus Cisplatin in Patients With Metastatic Melanoma or Other Advanced Solid Malignancies
Status: Enrolling
Updated: 2/24/2016
Ph 1 Trial of ADI-PEG 20 Plus Cisplatin in Patients With Metastatic Melanoma
Updated: 2/24/2016
Phase 1 Trial of ADI-PEG 20 Plus Cisplatin in Patients With Metastatic Melanoma or Other Advanced Solid Malignancies
Status: Enrolling
Updated: 2/24/2016
Click here to add this to my saved trials
Ph 1 Trial of ADI-PEG 20 Plus Cisplatin in Patients With Metastatic Melanoma
Updated: 2/24/2016
Phase 1 Trial of ADI-PEG 20 Plus Cisplatin in Patients With Metastatic Melanoma or Other Advanced Solid Malignancies
Status: Enrolling
Updated: 2/24/2016
Ph 1 Trial of ADI-PEG 20 Plus Cisplatin in Patients With Metastatic Melanoma
Updated: 2/24/2016
Phase 1 Trial of ADI-PEG 20 Plus Cisplatin in Patients With Metastatic Melanoma or Other Advanced Solid Malignancies
Status: Enrolling
Updated: 2/24/2016
Click here to add this to my saved trials
Donor Atorvastatin Treatment for Preventing Severe Acute Graft-Versus-Host Disease in Patients Undergoing Myeloablative Peripheral Blood Stem Cell Transplantation
Updated: 2/26/2016
Donor Statin Treatment for Prevention of Severe Acute GVHD After Myeloablative Hematopoietic Cell Transplantation
Status: Enrolling
Updated: 2/26/2016
Donor Atorvastatin Treatment for Preventing Severe Acute Graft-Versus-Host Disease in Patients Undergoing Myeloablative Peripheral Blood Stem Cell Transplantation
Updated: 2/26/2016
Donor Statin Treatment for Prevention of Severe Acute GVHD After Myeloablative Hematopoietic Cell Transplantation
Status: Enrolling
Updated: 2/26/2016
Click here to add this to my saved trials
Donor Atorvastatin Treatment for Preventing Severe Acute Graft-Versus-Host Disease in Patients Undergoing Myeloablative Peripheral Blood Stem Cell Transplantation
Updated: 2/26/2016
Donor Statin Treatment for Prevention of Severe Acute GVHD After Myeloablative Hematopoietic Cell Transplantation
Status: Enrolling
Updated: 2/26/2016
Donor Atorvastatin Treatment for Preventing Severe Acute Graft-Versus-Host Disease in Patients Undergoing Myeloablative Peripheral Blood Stem Cell Transplantation
Updated: 2/26/2016
Donor Statin Treatment for Prevention of Severe Acute GVHD After Myeloablative Hematopoietic Cell Transplantation
Status: Enrolling
Updated: 2/26/2016
Click here to add this to my saved trials
Donor Atorvastatin Treatment for Preventing Severe Acute Graft-Versus-Host Disease in Patients Undergoing Myeloablative Peripheral Blood Stem Cell Transplantation
Updated: 2/26/2016
Donor Statin Treatment for Prevention of Severe Acute GVHD After Myeloablative Hematopoietic Cell Transplantation
Status: Enrolling
Updated: 2/26/2016
Donor Atorvastatin Treatment for Preventing Severe Acute Graft-Versus-Host Disease in Patients Undergoing Myeloablative Peripheral Blood Stem Cell Transplantation
Updated: 2/26/2016
Donor Statin Treatment for Prevention of Severe Acute GVHD After Myeloablative Hematopoietic Cell Transplantation
Status: Enrolling
Updated: 2/26/2016
Click here to add this to my saved trials
Veliparib, Cisplatin, and Vinorelbine Ditartrate in Treating Patients With Recurrent and/or Metastatic Breast Cancer
Updated: 3/1/2016
Phase I Study of ABT-888 in Combination With Cisplatin and Vinorelbine for Patients With Advanced Triple Negative Breast Cancer and/or BRCA-Mutation Associated Breast Cancer
Status: Enrolling
Updated: 3/1/2016
Veliparib, Cisplatin, and Vinorelbine Ditartrate in Treating Patients With Recurrent and/or Metastatic Breast Cancer
Updated: 3/1/2016
Phase I Study of ABT-888 in Combination With Cisplatin and Vinorelbine for Patients With Advanced Triple Negative Breast Cancer and/or BRCA-Mutation Associated Breast Cancer
Status: Enrolling
Updated: 3/1/2016
Click here to add this to my saved trials
CAR T Cell Receptor Immunotherapy Targeting VEGFR2 for Patients With Metastatic Cancer
Updated: 3/1/2016
Phase I/II Study of Metastatic Cancer Using Lymphodepleting Conditioning Followed by Infusion of Anti-VEGFR2 Gene Engineered CD8+ Lymphocytes
Status: Enrolling
Updated: 3/1/2016
CAR T Cell Receptor Immunotherapy Targeting VEGFR2 for Patients With Metastatic Cancer
Updated: 3/1/2016
Phase I/II Study of Metastatic Cancer Using Lymphodepleting Conditioning Followed by Infusion of Anti-VEGFR2 Gene Engineered CD8+ Lymphocytes
Status: Enrolling
Updated: 3/1/2016
Click here to add this to my saved trials
Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery
Updated: 3/7/2016
Pre-operative Assessment and Post-Operative Outcomes of Elderly Women With Gynecologic Cancers
Status: Enrolling
Updated: 3/7/2016
Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery
Updated: 3/7/2016
Pre-operative Assessment and Post-Operative Outcomes of Elderly Women With Gynecologic Cancers
Status: Enrolling
Updated: 3/7/2016
Click here to add this to my saved trials
Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery
Updated: 3/7/2016
Pre-operative Assessment and Post-Operative Outcomes of Elderly Women With Gynecologic Cancers
Status: Enrolling
Updated: 3/7/2016
Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery
Updated: 3/7/2016
Pre-operative Assessment and Post-Operative Outcomes of Elderly Women With Gynecologic Cancers
Status: Enrolling
Updated: 3/7/2016
Click here to add this to my saved trials
Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery
Updated: 3/7/2016
Pre-operative Assessment and Post-Operative Outcomes of Elderly Women With Gynecologic Cancers
Status: Enrolling
Updated: 3/7/2016
Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery
Updated: 3/7/2016
Pre-operative Assessment and Post-Operative Outcomes of Elderly Women With Gynecologic Cancers
Status: Enrolling
Updated: 3/7/2016
Click here to add this to my saved trials
Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery
Updated: 3/7/2016
Pre-operative Assessment and Post-Operative Outcomes of Elderly Women With Gynecologic Cancers
Status: Enrolling
Updated: 3/7/2016
Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery
Updated: 3/7/2016
Pre-operative Assessment and Post-Operative Outcomes of Elderly Women With Gynecologic Cancers
Status: Enrolling
Updated: 3/7/2016
Click here to add this to my saved trials
Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery
Updated: 3/7/2016
Pre-operative Assessment and Post-Operative Outcomes of Elderly Women With Gynecologic Cancers
Status: Enrolling
Updated: 3/7/2016
Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery
Updated: 3/7/2016
Pre-operative Assessment and Post-Operative Outcomes of Elderly Women With Gynecologic Cancers
Status: Enrolling
Updated: 3/7/2016
Click here to add this to my saved trials
Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery
Updated: 3/7/2016
Pre-operative Assessment and Post-Operative Outcomes of Elderly Women With Gynecologic Cancers
Status: Enrolling
Updated: 3/7/2016
Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery
Updated: 3/7/2016
Pre-operative Assessment and Post-Operative Outcomes of Elderly Women With Gynecologic Cancers
Status: Enrolling
Updated: 3/7/2016
Click here to add this to my saved trials
Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery
Updated: 3/7/2016
Pre-operative Assessment and Post-Operative Outcomes of Elderly Women With Gynecologic Cancers
Status: Enrolling
Updated: 3/7/2016
Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery
Updated: 3/7/2016
Pre-operative Assessment and Post-Operative Outcomes of Elderly Women With Gynecologic Cancers
Status: Enrolling
Updated: 3/7/2016
Click here to add this to my saved trials
Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery
Updated: 3/7/2016
Pre-operative Assessment and Post-Operative Outcomes of Elderly Women With Gynecologic Cancers
Status: Enrolling
Updated: 3/7/2016
Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery
Updated: 3/7/2016
Pre-operative Assessment and Post-Operative Outcomes of Elderly Women With Gynecologic Cancers
Status: Enrolling
Updated: 3/7/2016
Click here to add this to my saved trials
Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery
Updated: 3/7/2016
Pre-operative Assessment and Post-Operative Outcomes of Elderly Women With Gynecologic Cancers
Status: Enrolling
Updated: 3/7/2016
Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery
Updated: 3/7/2016
Pre-operative Assessment and Post-Operative Outcomes of Elderly Women With Gynecologic Cancers
Status: Enrolling
Updated: 3/7/2016
Click here to add this to my saved trials
Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery
Updated: 3/7/2016
Pre-operative Assessment and Post-Operative Outcomes of Elderly Women With Gynecologic Cancers
Status: Enrolling
Updated: 3/7/2016
Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery
Updated: 3/7/2016
Pre-operative Assessment and Post-Operative Outcomes of Elderly Women With Gynecologic Cancers
Status: Enrolling
Updated: 3/7/2016
Click here to add this to my saved trials
Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery
Updated: 3/7/2016
Pre-operative Assessment and Post-Operative Outcomes of Elderly Women With Gynecologic Cancers
Status: Enrolling
Updated: 3/7/2016
Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery
Updated: 3/7/2016
Pre-operative Assessment and Post-Operative Outcomes of Elderly Women With Gynecologic Cancers
Status: Enrolling
Updated: 3/7/2016
Click here to add this to my saved trials
Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery
Updated: 3/7/2016
Pre-operative Assessment and Post-Operative Outcomes of Elderly Women With Gynecologic Cancers
Status: Enrolling
Updated: 3/7/2016
Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery
Updated: 3/7/2016
Pre-operative Assessment and Post-Operative Outcomes of Elderly Women With Gynecologic Cancers
Status: Enrolling
Updated: 3/7/2016
Click here to add this to my saved trials
Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery
Updated: 3/7/2016
Pre-operative Assessment and Post-Operative Outcomes of Elderly Women With Gynecologic Cancers
Status: Enrolling
Updated: 3/7/2016
Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery
Updated: 3/7/2016
Pre-operative Assessment and Post-Operative Outcomes of Elderly Women With Gynecologic Cancers
Status: Enrolling
Updated: 3/7/2016
Click here to add this to my saved trials
Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery
Updated: 3/7/2016
Pre-operative Assessment and Post-Operative Outcomes of Elderly Women With Gynecologic Cancers
Status: Enrolling
Updated: 3/7/2016
Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery
Updated: 3/7/2016
Pre-operative Assessment and Post-Operative Outcomes of Elderly Women With Gynecologic Cancers
Status: Enrolling
Updated: 3/7/2016
Click here to add this to my saved trials
Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery
Updated: 3/7/2016
Pre-operative Assessment and Post-Operative Outcomes of Elderly Women With Gynecologic Cancers
Status: Enrolling
Updated: 3/7/2016
Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery
Updated: 3/7/2016
Pre-operative Assessment and Post-Operative Outcomes of Elderly Women With Gynecologic Cancers
Status: Enrolling
Updated: 3/7/2016
Click here to add this to my saved trials
Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery
Updated: 3/7/2016
Pre-operative Assessment and Post-Operative Outcomes of Elderly Women With Gynecologic Cancers
Status: Enrolling
Updated: 3/7/2016
Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery
Updated: 3/7/2016
Pre-operative Assessment and Post-Operative Outcomes of Elderly Women With Gynecologic Cancers
Status: Enrolling
Updated: 3/7/2016
Click here to add this to my saved trials
Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery
Updated: 3/7/2016
Pre-operative Assessment and Post-Operative Outcomes of Elderly Women With Gynecologic Cancers
Status: Enrolling
Updated: 3/7/2016
Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery
Updated: 3/7/2016
Pre-operative Assessment and Post-Operative Outcomes of Elderly Women With Gynecologic Cancers
Status: Enrolling
Updated: 3/7/2016
Click here to add this to my saved trials
Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery
Updated: 3/7/2016
Pre-operative Assessment and Post-Operative Outcomes of Elderly Women With Gynecologic Cancers
Status: Enrolling
Updated: 3/7/2016
Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery
Updated: 3/7/2016
Pre-operative Assessment and Post-Operative Outcomes of Elderly Women With Gynecologic Cancers
Status: Enrolling
Updated: 3/7/2016
Click here to add this to my saved trials
Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery
Updated: 3/7/2016
Pre-operative Assessment and Post-Operative Outcomes of Elderly Women With Gynecologic Cancers
Status: Enrolling
Updated: 3/7/2016
Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery
Updated: 3/7/2016
Pre-operative Assessment and Post-Operative Outcomes of Elderly Women With Gynecologic Cancers
Status: Enrolling
Updated: 3/7/2016
Click here to add this to my saved trials
Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery
Updated: 3/7/2016
Pre-operative Assessment and Post-Operative Outcomes of Elderly Women With Gynecologic Cancers
Status: Enrolling
Updated: 3/7/2016
Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery
Updated: 3/7/2016
Pre-operative Assessment and Post-Operative Outcomes of Elderly Women With Gynecologic Cancers
Status: Enrolling
Updated: 3/7/2016
Click here to add this to my saved trials
Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery
Updated: 3/7/2016
Pre-operative Assessment and Post-Operative Outcomes of Elderly Women With Gynecologic Cancers
Status: Enrolling
Updated: 3/7/2016
Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery
Updated: 3/7/2016
Pre-operative Assessment and Post-Operative Outcomes of Elderly Women With Gynecologic Cancers
Status: Enrolling
Updated: 3/7/2016
Click here to add this to my saved trials
Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery
Updated: 3/7/2016
Pre-operative Assessment and Post-Operative Outcomes of Elderly Women With Gynecologic Cancers
Status: Enrolling
Updated: 3/7/2016
Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery
Updated: 3/7/2016
Pre-operative Assessment and Post-Operative Outcomes of Elderly Women With Gynecologic Cancers
Status: Enrolling
Updated: 3/7/2016
Click here to add this to my saved trials
Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery
Updated: 3/7/2016
Pre-operative Assessment and Post-Operative Outcomes of Elderly Women With Gynecologic Cancers
Status: Enrolling
Updated: 3/7/2016
Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery
Updated: 3/7/2016
Pre-operative Assessment and Post-Operative Outcomes of Elderly Women With Gynecologic Cancers
Status: Enrolling
Updated: 3/7/2016
Click here to add this to my saved trials
Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery
Updated: 3/7/2016
Pre-operative Assessment and Post-Operative Outcomes of Elderly Women With Gynecologic Cancers
Status: Enrolling
Updated: 3/7/2016
Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery
Updated: 3/7/2016
Pre-operative Assessment and Post-Operative Outcomes of Elderly Women With Gynecologic Cancers
Status: Enrolling
Updated: 3/7/2016
Click here to add this to my saved trials
Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery
Updated: 3/7/2016
Pre-operative Assessment and Post-Operative Outcomes of Elderly Women With Gynecologic Cancers
Status: Enrolling
Updated: 3/7/2016
Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery
Updated: 3/7/2016
Pre-operative Assessment and Post-Operative Outcomes of Elderly Women With Gynecologic Cancers
Status: Enrolling
Updated: 3/7/2016
Click here to add this to my saved trials
Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery
Updated: 3/7/2016
Pre-operative Assessment and Post-Operative Outcomes of Elderly Women With Gynecologic Cancers
Status: Enrolling
Updated: 3/7/2016
Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery
Updated: 3/7/2016
Pre-operative Assessment and Post-Operative Outcomes of Elderly Women With Gynecologic Cancers
Status: Enrolling
Updated: 3/7/2016
Click here to add this to my saved trials
Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery
Updated: 3/7/2016
Pre-operative Assessment and Post-Operative Outcomes of Elderly Women With Gynecologic Cancers
Status: Enrolling
Updated: 3/7/2016
Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery
Updated: 3/7/2016
Pre-operative Assessment and Post-Operative Outcomes of Elderly Women With Gynecologic Cancers
Status: Enrolling
Updated: 3/7/2016
Click here to add this to my saved trials
Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery
Updated: 3/7/2016
Pre-operative Assessment and Post-Operative Outcomes of Elderly Women With Gynecologic Cancers
Status: Enrolling
Updated: 3/7/2016
Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery
Updated: 3/7/2016
Pre-operative Assessment and Post-Operative Outcomes of Elderly Women With Gynecologic Cancers
Status: Enrolling
Updated: 3/7/2016
Click here to add this to my saved trials
Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery
Updated: 3/7/2016
Pre-operative Assessment and Post-Operative Outcomes of Elderly Women With Gynecologic Cancers
Status: Enrolling
Updated: 3/7/2016
Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery
Updated: 3/7/2016
Pre-operative Assessment and Post-Operative Outcomes of Elderly Women With Gynecologic Cancers
Status: Enrolling
Updated: 3/7/2016
Click here to add this to my saved trials
Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery
Updated: 3/7/2016
Pre-operative Assessment and Post-Operative Outcomes of Elderly Women With Gynecologic Cancers
Status: Enrolling
Updated: 3/7/2016
Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery
Updated: 3/7/2016
Pre-operative Assessment and Post-Operative Outcomes of Elderly Women With Gynecologic Cancers
Status: Enrolling
Updated: 3/7/2016
Click here to add this to my saved trials